In a paper published in September 2020, Gradecki S. et al. reported their experience of immunostaining of PRAME on 155 cases of metastatic melanoma, 54 of which were to lymph node and 101 to non-lymph node sites. The gene discussed is PRAME; the disease is metastatic melanoma.